G蛋白结合受体在心血管疾病中的作用
Yuanqiang Li1, Boyu Li2, Wei-Dong Chen3,4
1State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Frontiers in cardiovascular medicine
|June 21, 2023
概括
G蛋白结合受体 (GPCR) 在心血管疾病 (CVD) 中至关重要,影响心脏和血管功能. 了解GPCR为治疗这些普遍疾病提供了新的治疗点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,每年全球约30%的死亡是其原因.
- G-蛋白结合受体 (GPCRs) 是不可分割的细胞表面受体,对调节生理和病理细胞过程至关重要.
- 现有的心血管疾病治疗方法,包括β-阻断剂,以及相当一部分心血管药物向GPCRs,突出显示了它们的治疗重要性.
研究的目的:
- 审查和讨论GPCRs在心血管系统功能中的多方面的作用,包括血管和心脏的视角.
- 在血管和心脏疾病的背景下分析多个GPCR的复杂调节机制.
- 根据GPCR研究,确定针对心血管疾病的新疗法策略和药物开发机会.
主要方法:
- 文献综述和对心血管环境中GPCR结构和功能的现有研究进行综合.
- 对将GPCR活性与心血管生理学和病理学联系起来的数据的分析.
- 探索针对GPCR治疗心脏病的治疗干预措施.
主要成果:
- GPCRs在调节心血管系统功能方面发挥着关键作用,影响心脏和血管系统.
- 有证据表明,许多GPCRs与各种心血管疾病的发展和进展有关.
- 向GPCR已被证明在当前心血管疾病治疗中有效,并且代表了未来药物开发的重要领域.
结论:
- GPCRs是心血管健康和疾病的不可或缺的调节者.
- 对心血管疾病中GPCRs的全面理解对于推进治疗选择至关重要.
- 这一审查为开发针对GPCRs的创新药物提供了基础,以有效打击心血管疾病.
相关概念视频
G-protein Coupled Receptors
120.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.4K
G Protein-coupled Receptors
12.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.3K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K
GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


